Published in Brain on April 05, 2007
Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci (2015) 4.01
Acupuncture mobilizes the brain's default mode and its anti-correlated network in healthy subjects. Brain Res (2009) 1.60
Oscillations in sensorimotor cortex in movement disorders: an electrocorticography study. Brain (2012) 1.54
Early cognitive and language skills are linked to resting frontal gamma power across the first 3 years. Behav Brain Res (2008) 1.25
Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons. Cereb Cortex (2010) 1.25
Acupuncture, the limbic system, and the anticorrelated networks of the brain. Auton Neurosci (2010) 1.21
Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease. Cereb Cortex (2013) 1.08
The Amsterdam Resting-State Questionnaire reveals multiple phenotypes of resting-state cognition. Front Hum Neurosci (2013) 1.03
L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: a resting state fMRI study. Front Syst Neurosci (2012) 0.97
Progressive resistance exercise and Parkinson's disease: a review of potential mechanisms. Parkinsons Dis (2011) 0.96
Consistent spectral predictors for dynamic causal models of steady-state responses. Neuroimage (2011) 0.95
Investigation of EEG abnormalities in the early stage of Parkinson's disease. Cogn Neurodyn (2013) 0.93
The ARSQ 2.0 reveals age and personality effects on mind-wandering experiences. Front Psychol (2014) 0.92
Cortical information flow in Parkinson's disease: a composite network/field model. Front Comput Neurosci (2013) 0.91
Dopaminergic therapy in Parkinson's disease decreases cortical beta band coherence in the resting state and increases cortical beta band power during executive control. Neuroimage Clin (2013) 0.89
The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study. J Neurooncol (2008) 0.88
Altered hub configurations within default mode network following acupuncture at ST36: a multimodal investigation combining fMRI and MEG. PLoS One (2013) 0.87
The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J Neurol (2011) 0.87
Non-linear dynamical analysis of EEG time series distinguishes patients with Parkinson's disease from healthy individuals. Front Neurol (2013) 0.86
Alpha and beta EEG power reflects L-dopa acute administration in parkinsonian patients. Front Aging Neurosci (2014) 0.84
Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study. Neuroimage Clin (2013) 0.83
Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study. J Neurophysiol (2014) 0.83
Traumatic brain injury detection using electrophysiological methods. Front Hum Neurosci (2015) 0.82
Slowing of EEG background activity in Parkinson's and Alzheimer's disease with early cognitive dysfunction. Front Aging Neurosci (2014) 0.82
Acupuncture induces divergent alterations of functional connectivity within conventional frequency bands: evidence from MEG recordings. PLoS One (2012) 0.82
Elevated synchrony in Parkinson disease detected with electroencephalography. Ann Neurol (2015) 0.82
A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming. Neuroimage Clin (2012) 0.81
Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats. Exp Brain Res (2008) 0.81
Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology. Transl Res (2016) 0.80
Influences of COMT and 5-HTTLPR polymorphisms on cognitive flexibility in healthy women: inhibition of prepotent responses and memory updating. PLoS One (2014) 0.80
Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach. Int J Alzheimers Dis (2012) 0.79
Power spectra for screening parkinsonian patients for mild cognitive impairment. Ann Clin Transl Neurol (2014) 0.79
Task-related activity in sensorimotor cortex in Parkinson's disease and essential tremor: changes in beta and gamma bands. Front Hum Neurosci (2015) 0.79
Magnetoencephalography. Pract Neurol (2014) 0.79
Practice changes beta power at rest and its modulation during movement in healthy subjects but not in patients with Parkinson's disease. Brain Behav (2015) 0.78
Complexity of resting-state EEG activity in the patients with early-stage Parkinson's disease. Cogn Neurodyn (2016) 0.77
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study. Neuroimage Clin (2013) 0.77
Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus. Neuroimage Clin (2015) 0.76
Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease. Neuroimage Clin (2017) 0.75
Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia. PLoS One (2013) 0.75
Quantitative EEG and Cognitive Decline in Parkinson's Disease. Parkinsons Dis (2016) 0.75
Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study. Sleep (2016) 0.75
Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson's disease patients. BMC Neurosci (2016) 0.75
Neuromagnetic effects of pico-Tesla stimulation. Physiol Meas (2015) 0.75
Network effects of deep brain stimulation. J Neurophysiol (2015) 0.75
Quantitative EEG (QEEG) Measures Differentiate Parkinson's Disease (PD) Patients from Healthy Controls (HC). Front Aging Neurosci (2017) 0.75
Age-related differences in inhibitory control and memory updating in boys with Asperger syndrome. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet (1986) 4.54
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Small-world and scale-free organization of voxel-based resting-state functional connectivity in the human brain. Neuroimage (2008) 4.08
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain (2008) 3.36
Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from neurosyphilis patients before and after antibiotic treatment. J Clin Microbiol (1991) 2.43
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology (1995) 1.86
Small-world networks and epilepsy: graph theoretical analysis of intracerebrally recorded mesial temporal lobe seizures. Clin Neurophysiol (2007) 1.81
White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain (1992) 1.77
Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet (1982) 1.74
Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity. Eur J Neurol (2013) 1.69
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease. Neuroimage (2006) 1.64
The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res (1990) 1.57
The specificity of the 'nonspecific' midline and intralaminar thalamic nuclei. Trends Neurosci (1994) 1.56
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 1.56
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.51
Prevalence of smell loss in Parkinson's disease--a multicenter study. Parkinsonism Relat Disord (2009) 1.50
X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet (1993) 1.48
Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience (1993) 1.47
Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm IGF Res (2000) 1.44
A case of progressive aphasia without dementia: "temporal" Pick's disease? J Neurol Neurosurg Psychiatry (1990) 1.42
The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Horm IGF Res (2005) 1.42
[The practice guideline 'Diagnosis and pharmaceutical treatment of dementia']. Ned Tijdschr Geneeskd (2006) 1.38
Identifying confounds to increase specificity during a "no task condition". Evidence for hippocampal connectivity using fMRI. Neuroimage (2003) 1.37
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol (2001) 1.32
Synchronization likelihood with explicit time-frequency priors. Neuroimage (2006) 1.31
Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology (1987) 1.30
Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br Med J (Clin Res Ed) (1986) 1.30
Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: an MEG study. Neuroimage (2008) 1.28
The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med (2001) 1.28
EEG synchronization likelihood in mild cognitive impairment and Alzheimer's disease during a working memory task. Clin Neurophysiol (2004) 1.24
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord (2001) 1.23
Cognition is related to resting-state small-world network topology: an magnetoencephalographic study. Neuroscience (2010) 1.22
Chronic manganese intoxication. Arch Neurol (1989) 1.22
A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient. J Neurol Neurosurg Psychiatry (1988) 1.22
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med (1998) 1.22
Inter-observer variability of the EEG diagnosis of seizures in comatose patients. Seizure (2008) 1.19
Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J Neurol Sci (1994) 1.17
Indications for network regularization during absence seizures: weighted and unweighted graph theoretical analyses. Exp Neurol (2009) 1.15
Resting state oscillatory brain dynamics in Parkinson's disease: an MEG study. Clin Neurophysiol (2006) 1.15
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol (1992) 1.11
Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med (1997) 1.10
Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's disease. Neuroimage (2011) 1.10
Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum Mol Genet (1996) 1.07
Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci U S A (1992) 1.07
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med (1998) 1.06
Global dynamical analysis of the EEG in Alzheimer's disease: frequency-specific changes of functional interactions. Clin Neurophysiol (2008) 1.05
The relationship between structural and functional connectivity: graph theoretical analysis of an EEG neural mass model. Neuroimage (2009) 1.05
Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med (1997) 1.04
Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J Comp Neurol (1990) 1.03
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys. Mov Disord (1994) 1.01
Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer's disease: a multicentric EEG study. Eur J Neurosci (2004) 1.00
Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. J Neurol (1998) 1.00
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease. Synapse (2001) 1.00
Endophenotypes in a dynamically connected brain. Behav Genet (2010) 0.99
Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology (2008) 0.99
[123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease. J Neural Transm (Vienna) (2001) 0.99
Identification of axial rigidity during locomotion in Parkinson disease. Arch Phys Med Rehabil (1999) 0.99
The influence of brain tumor treatment on pathological delta activity in MEG. Neuroimage (2003) 0.99
Depression in Parkinson's disease. The impact of symptom overlap on prevalence. Psychosomatics (1998) 0.99
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol (1993) 0.96
The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm IGF Res (2005) 0.96
Abnormal H-reflexes in periodic limb movement disorder; impact on understanding the pathophysiology of the disorder. Clin Neurophysiol (2005) 0.94
Magnetoencephalography as a putative biomarker for Alzheimer's disease. Int J Alzheimers Dis (2011) 0.94
Periodic limb movement disorder and restless legs syndrome in dialysis patients. Nephrology (Carlton) (2004) 0.94
Densitometrical analysis of opioid receptor ligand binding in the human striatum--I. Distribution of mu opioid receptor defines shell and core of the ventral striatum. Neuroscience (1996) 0.93
Interictal network properties in mesial temporal lobe epilepsy: a graph theoretical study from intracerebral recordings. Clin Neurophysiol (2013) 0.92
The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way. Eur J Pharmacol (1992) 0.92
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy. Eur J Pharmacol (1999) 0.92
Motor perseveration is an early sign of Parkinson's disease. Neurology (2001) 0.92
Age-related cognitive effects of ECT and ECT-induced mood improvement in depressive patients. Depress Anxiety (2006) 0.91
Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneuroendocrinology (2003) 0.91
Effect of early and late syphilis on central nervous system: cerebrospinal fluid changes and neurological deficit. Genitourin Med (1987) 0.91
Neurosyphilis: a changing diagnostic problem? Eur Neurol (1987) 0.91
Decrease of non-linear structure in the EEG of Alzheimer patients compared to healthy controls. Clin Neurophysiol (1999) 0.91
MEG resting state functional connectivity in Parkinson's disease related dementia. J Neural Transm (Vienna) (2008) 0.90
Preclinical (premotor) Parkinson's disease. J Neurol (2000) 0.90
Localization of fast MEG waves in patients with brain tumors and epilepsy. Brain Topogr (2003) 0.88
The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study. J Neurooncol (2008) 0.88
Connectivity in MEG resting-state networks increases after resective surgery for low-grade glioma and correlates with improved cognitive performance. Neuroimage Clin (2012) 0.87
Quality of life and cognitive function in patients with pituitary insufficiency. Psychother Psychosom (1998) 0.87
The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J Neurol (2011) 0.87
EEG synchronisation during sleep-related epileptic seizures as a new tool to discriminate confusional arousals from paroxysmal arousals: preliminary findings. Neurol Sci (2005) 0.86
Odour identification and discrimination in Dutch adults over 45 years. Rhinology (2008) 0.86
[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls. Eur J Nucl Med (1997) 0.86
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J Neural Transm (Vienna) (2000) 0.84
The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome. Horm Behav (2011) 0.84
A neural complexity measure applied to MEG data in Alzheimer's disease. Clin Neurophysiol (2003) 0.84
Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy. Eur J Neurol (2011) 0.84